This is a sponsored post about a Lupus study from DxTerity that contains links. I have received compensation in exchange for posting this info.

Whether you have had lupus for one year or one decade, you are probably well aware that one-size fits all treatments don’t work for people diagnosed with the disease. The truth is, we need more personalized care based on what is happening inside the body of each individual. One way to get closer to this type of unique, personalized care is by taking part in clinical studies. Sometimes, because of severe symptoms, distance or even lack of transportation, it can be challenging to take part in these studies, but right now those of us diagnosed with lupus have an opportunity to help advance personalized lupus care with an at-home study called ELEVATE from DxTerity.

What is ELEVATE?

Right now there is a new at-home study called ELEVATE that is seeking volunteers in order to better understand the unique gene activity of different Lupus patients. The goal of the study is to survey advanced genomic markers and find simpler ways to test for more common blood proteins.

Breaking this down, one of the key markers that will be evaluated in this study is Type-1 Interferon, also known as IFN-1. IFN-1 is a crucial RNA biomarker, and its levels correlate with how severe lupus symptoms can be. By knowing your IFN-1 status, it can help you better understand the potential progression of your disease and help you in the decision-making process when it comes to better controlling your health.

What Commitment Does ELEVATE Involve?

If you qualify to take part in the ELEVATE study, here is what is expected from you over the time frame of one year:

• Perform 4-5 simple, at-home collections throughout the year
• Ship the collection samples in a prepaid package
• Provide access to your medical records
• Take part in answering surveys about your health status

What You Receive in Exchange For Your Time

DxTerity is offering a nice compensation package to those who are taking part in ELEVATE. In addition to possibly letting you know if your IFN-1 status is high or low, you will also receive:

• $50 on completion of the first collection and questionnaire
• And, up to $150 additional compensation.

You’ll also know you are helping to advance precision care for thousands of people living with Lupus, and will be helping researchers develop new tools to monitor Lupus disease activity, without leaving your home.

Learn More About DxTerity

If taking part in the ELEVATE study interests you, you probably want to know more about the company behind the study. DxTerity is a genomics research company developing tests to help bring precision medicine to autoimmune diseases. In DxTerity’s vision for the future, we can use easy finger-stick kits to monitor our health from home. We can help create that future by participating in clinical studies.

Previously, in a study called LIFT, patients like us demonstrated for the first time that it’s possible to measure genomic markers for Lupus from home. There are more markers that DxTerity wants to test to see if they can be used to monitor disease activity.

Are you interested in signing up for ELEVATE? For more information and to see if you qualify, click here.  

Here’s to helping all of us diagnosed with lupus learn more about biomarkers and precision medicine that can help us in the future better manage our illness and hopefully have improved quality of life!

Thanks for reading, LupusChicks XOXO

Marisa